The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study.
Sissel Gyrid Freim WahlHong Yan DaiElisabeth Fritzke EmdalThomas BergTarje Onsøien HalvorsenAnine Larsen OttestadMarius Lund-IversenOdd Terje BrustugunDagny FørdeErna-Elise PaulsenTom DonnemSigve AndersenBjørn Henning GrønbergElin RichardsenPublished in: Cancers (2021)
KRAS status or KRAS mutation subtype did not have any significant influence on PFS or OS.